News
Novo Nordisk, GoodRX, CVS
Digest more
Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...
GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results